In the BioHarmony Drug Report Database
Corticotropin
Acth, Acthar, Corticotropin, H.p. Acthar Gel, Purified Cortrophin Gel (corticotropin) is a protein pharmaceutical. Corticotropin was first approved as Acth on 1982-01-01. It is used to treat collagen diseases, erythema multiforme, infantile spasms, multiple sclerosis, and nephrotic syndrome amongst others in the USA. The pharmaceutical is active against adrenocorticotropic hormone receptor. In addition, it is known to target CRHR1-IT1-CRHR1 protein, melanocortin receptor 5, melanocortin receptor 4, melanocyte-stimulating hormone receptor, melanocortin receptor 3, and corticotropin-releasing factor receptor 2.
Trade Name
|
Acth, Acthar, Corticotropin, H.p. Acthar Gel, Purified Cortrophin Gel |
|---|---|
Common Name
|
corticotropin |
ChEMBL ID
|
CHEMBL1201610 |
Indication
|
collagen diseases, erythema multiforme, infantile spasms, multiple sclerosis, nephrotic syndrome, optic neuritis, rheumatic diseases, sarcoidosis, serum sickness, uveitis |
Drug Class
|
Atropine derivatives |
Image (chem structure or protein)